SWM
PFE icon

Silverlake Wealth Management’s Pfizer PFE Stock Holding History

Silverlake Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
80,679
-3,698
-4% -$96.7K 0.37% 83
2026
Q1 		$2.37M Buy
84,377
+433
+0.5% +$11.5K 0.49% 54
2025
Q4 		$2.09M Sell
83,944
-3,287
-4% -$82.9K 0.47% 61
2025
Q3 		$2.22M Buy
87,231
+3,031
+4% +$74.8K 0.54% 45
2025
Q2 		$2.04M Buy
84,200
+8,263
+11% +$193K 0.59% 46
2025
Q1 		$1.92M Sell
75,937
-752
-1% -$19.7K 0.73% 41
2024
Q4 		$2.03M Buy
76,689
+5,966
+8% +$162K 0.78% 30
2024
Q3 		$2.05M Buy
70,723
+11,833
+20% +$345K 0.78% 29
2024
Q2 		$1.65M Buy
58,890
+6,042
+11% +$166K 0.68% 38
2024
Q1 		$1.47M Buy
52,848
+5,223
+11% +$145K 0.75% 31
2023
Q4 		$1.37M Sell
47,625
-1,604
-3% -$48.5K 0.76% 31
2023
Q3 		$1.63M Sell
49,229
-2,474
-5% -$87.5K 0.92% 23
2023
Q2 		$1.9M Buy
51,703
+944
+2% +$36.7K 1.05% 19
2023
Q1 		$2.07M Sell
50,759
-510
-1% -$22K 1.26% 15
2022
Q4 		$2.63M Sell
51,269
-887
-2% -$42.5K 1.64% 9
2022
Q3 		$2.28M Sell
52,156
-5
-0% -$243 1.55% 9
2022
Q2 		$2.73M Buy
52,161
+1,592
+3% +$81.1K 1.78% 8
2022
Q1 		$2.62M Sell
50,569
-3,034
-6% -$157K 1.5% 8
2021
Q4 		$3.17M Buy
+53,603
New +$2.66M 1.7% 7

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Silverlake Wealth Management's PFE Position: Q2 2026 in Review

Silverlake Wealth Management reduced its Pfizer (PFE) stake by 4.4% in Q2 2026, selling an estimated $96.7K and leaving 80,679 shares worth $1.94M. The position accounts for 0.37% of the portfolio, ranked #83.

Silverlake Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.17M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Silverlake Wealth Management held 80,679 shares of Pfizer worth $1.94M as of Q2 2026.
  • Silverlake Wealth Management sold 3,698 Pfizer shares in Q2 2026, an estimated $96.7K.
  • Pfizer made up 0.37% of Silverlake Wealth Management's portfolio in Q2 2026, its #83 holding.
  • Silverlake Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Silverlake Wealth Management's Pfizer position peaked at $3.17M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.